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Drug encapsulation into systems able to deliver at a 
certain site a given amount of drug over well defined 
periods is used for controlling the drug release. By 
encapsulating drugs in biodegradable polymeric 
microspheres, which in turn are embedded in a hydrogel 
body, several release mechanisms contribute to the tuning 
of the release profile of the drug. Mixed hydrogels, 
consisting of random copolymers of 2-hydroxyethyl 
methacrylate (HEMA) and methyl methacrylate (MMA) 
cross-linked by ethyleneglycol dimethacrylate (EGDMA), 
were chosen to serve as body of the device. 
Biodegradable poly-ε-caprolactone (PCL) microspheres, 
in which drugs such as levonorgestrel (LNG) were 
encapsulated, were physically embedded into hydrogels. 
The hydrogel-microspheres composites has been 
characterised in terms of water swelling and tensile 
properties. The release profile of the developed multi-
component drug delivery biomaterial will be discussed.  
 
INTRODUCTION 
Controlled release systems based on microspheres are 
extensively studied drug delivery systems, due to their 
ability to maintain optimal drug concentration over a 
prolonged time, to protect and stabilize the drug and 
increase the patient compliance by reducing the 
administration frequency. Poly-ε-caprolactone (PCL) is 
one of the widely used biodegradable and biocompatible 
aliphatic polyester, having semicrystalline structure and a 
very low glass transition (-60 °C). Compared to other 
polymers, degradation of PCL is slow making it suitable 
for long-term delivery; due to its good drug permeability 
and biocompatibility, PCL microspheres including drugs 
dispersed in the polymer matrix have been extensively 
evaluated for the delivery of active compounds over long 
periods [1].  
Hydrogels are polymers in three-dimensional network 
arrangements that are insoluble, but able to absorb and 
retain large amounts of water. In comparison with other 
synthetic biomaterials, hydrogels closely resemble natural 
tissues due to their relatively high water content and soft 
and rubbery consistency, being therefore frequently used 
for biomedical and pharmaceutical applications. The 
release of the drug from hydrogel controlled release 
systems is affected by the rate of water (body fluids) 
diffusion into the polymer, which in turn depends on the 
chemical structure of the polymer (polarity of the polymer 
segments, glass transition temperature, flexibility of the 
polymer backbone) and on the cross-link density and 
inter-chain interactions. The physico-chemical properties 
of the incorporated drug (size, shape, hydrophilicity) and 
the loading levels have an important contribution to the 
drug release from these systems [2]. Poly(2-hydroxyethyl 
methacrylate) (pHEMA) - based hydrogels have been 
investigated for several biomedical applications, such as 
substrates for cellular and tissue engineering and drug 
delivery devices, thanks to their ascertained non-toxicity 
and widespread use as soft contact lenses and intraocular 
lenses. 
By embedding microspheres containing drugs into 
hydrogels, two different release mechanisms can be 
combined [3]: diffusion through the polymeric matrix for 
the microcarriers and diffusion through the hydrophilic 
matrix for the hydrogel. Combining hydrogels and 
microspheres lead to composites with unique release 
characteristics, whose mechanical properties could 
markedly differ from the properties of the initial hydrogel, 
affecting therefore the ability of the developed device to 
be used as an implant. For altering the mechanical 
properties of a hydrogel, the easiest way is to change the 
relative amounts of physically stronger co-monomer(s) - 
thus modifying the stiffness of the backbone polymer or 
its hydrophilicity - and cross-linking agents – changing 
the cross-linking density of the polymer network. 
Changes in the polymer will affect not only the 
mechanical properties, but also other behaviour of the 
material as well.  
The softness, flexibility and mechanical integrity of drug 
delivery devices based on non-biodegradable materials 
used as implantable systems, which can be inserted and 
withdrawn on request, are of major importance with 




After removal of dissolved oxygen – by nitrogen bubbling 
for 5 min - from monomer mixtures composed of HEMA 
and MMA, and containing 0.1 – 0.5% (w/w) EGDMA, 
into some monomer mixtures either LNG was added, or 
PCL microspheres (with drug or drug-free) were 
dispersed. Subsequently, the organic phases were mixed 
in reagent glasses in a ratio of 3:1 with aqueous solutions 
of redox initiators (6.4 mg K2S2O8 and 3.2 mg Na2S2O5 / 
ml water). The nitrogen bubbling continued for another 
15 minutes, then the reagent glasses were closed and left 
under the nitrogen blanket at room temperature until the 
gelation of the reaction mass was visible. Subsequently, 
the viscous liquid was stirred to achieve uniform 
composition and was either aspirated into one-way plastic 
syringes or moulded between two glass plates spaced at 
approximately 1 mm distance with a rubber spacer, and 
let to polymerise overnight at room temperature.  
The hydrogel rods or membranes respectively obtained 
were washed for at least five days with distilled water, 
with daily water changes, to eliminate the unreacted 
monomer, and were stored in distilled water. 
Swelling behaviour 
Freeze-dried rods of pHEMA-based hydrogels were 
immersed in distilled water at room temperature. At 
certain time intervals, the hydrogel pieces were extracted 
from the water, blotted dry with paper towel and weighed.  
Tensile measurements 
Specimens were cut from every pHEMA-based hydrogel 
membrane in a dumbbell shape with a custom-made steel 
knife. The dimensions of the swollen samples were L = 
40 mm and w = 4 mm, with variable thicknesses as a 
function of the spacer thickness and hydrogel 
composition. Hydrated grease-covered samples were 
mounted on the Instron equipped with a 10 N load cell, 
and a pretension of 0.2 N was applied at a rate of the 
cross-head displacement of 20 mm / min. During the 
measurements, a constant displacement of the cross-head 
of 10 mm / min was used. The rate of displacement 
produced fracture in the specimen within 1/2 to 5 min of 
test initiation, as suggested by ASTM D 638-99.  
 
RESULTS AND DISCUSSION 
 
Different hydrogel formulations manifested different 
swelling ratios and tensile parameters, as a function of 
their hydrophobic co-monomer and cross-linker content. 
The elasticity modulus strongly increased with the 
increase of the cross-linker content, but this component 
brought about also the side effect of increased brittleness. 
                                                    
                                                    
                                                    
                                                    
                                                    
                                                    
































Figure 1. Young's modulus values for pHEMA-based 
hydrogel membranes with different compositions  
 
As shown in Figure 1, The increase of the hydrophobic 
co-monomer content lead to an increase of the elasticity 
modulus and to an improvement of the parameters at 
break (not shown). Embedding microspheres into the 
hydrogel – for a certain loading range - did not negatively 
influence the tensile parameters of the materials; on the 
contrary, a slight increase of the elasticity modulus was 
registered. The increase of MMA content lead, as 
expected, to a progressively slow down of LNG diffusion 
through pre-formed hydrogel membranes; the LNG 
release out of hydrogel devices with dissolved drug was 
influenced mainly during the first release days, but was 
relatively similar for the following release stage.  
Drug-loaded PCL microspheres, dispersed in a pHEMA-
based hydrogel, form composites where the hydrogel is 
not only a physical support for the drug loaded 
microspheres, but it also acts as an additional diffusion 
barrier. This ability of the hydrogel could be further 
developed by performing the polymerisation of the 
HEMA with a hydrophobic co-monomer, such as MMA. 
Potential applications of this drug delivery system could 
be found in the design of implantable devices with long-




The developed multi-component material has the ability 
to preserve in a high degree the mechanical properties 
characteristics for hydrogels upon embedding the 
microspheres into the hydrogel body, allowing their use 
as implantable drug delivery devices. These multi-
component devices are of particular interest in drug 
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